Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi
- 1 August 2015
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 761, 383-390
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Comparative efficacy of aclidinium versus glycopyrronium and tiotropium, as maintenance treatment of moderate to severe COPD patients: a systematic review and network meta-analysisInternational Journal of Chronic Obstructive Pulmonary Disease, 2013
- Efficacy and safety of NVA237versusplacebo and tiotropium in patients with COPD: the GLOW2 studyEuropean Respiratory Journal, 2012
- Novel bronchodilators for the treatment of chronic obstructive pulmonary diseaseTrends in Pharmacological Sciences, 2011
- Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agentsRespiratory Research, 2010
- Onset of Effect of Aclidinium, a Novel, Long-Acting Muscarinic Antagonist, in Patients with COPDCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2010
- Exploring the Mechanism of Agonist Efficacy: A Relationship between Efficacy and Agonist Dissociation Rate at the Muscarinic M3 ReceptorMolecular Pharmacology, 2009
- Onset and Duration of Action of Formoterol and Tiotropium in Patients with Moderate to Severe COPDRespiration, 2006
- Tiotropium bromide: A new long-acting bronchodilator for the treatment of chronic obstructive pulmonary diseaseClinical Therapeutics, 2005
- Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea‐pig airwaysBritish Journal of Pharmacology, 1999
- Role of the Parasympathetic System in Airway Obstruction Due to EmphysemaNew England Journal of Medicine, 1984